Biotech's Recently Under the Microscope, Analyst Coverage
September 20 2017 - 8:00AM
InvestorsHub NewsWire
Advaxis, Inc. (NASDAQ: ADXS), a clinical
stage biotechnology company, focused on Lm-LLO cancer
immunotherapies has announced that Anthony Lombardo, interim chief
executive officer, will present a company overview at the Cantor
Fitzgerald Global Healthcare Conference being held Sept. 25-27,
2017 in New York. The company’s shares have retreated almost 30%
this month. Anavex Life Sciences Corp (NASDAQ:
AVXL) was issued U.S. Patent Number 9,750,746 entitled
“ANAVEX 2-73 and certain anticholinesterase inhibitors composition
and method for neuroprotection. The issued patent offers protection
through 2033. After AVXL shares fell over 40% this summer, they
have gained some traction and recouped about half of that share
loss. Avid Bioservices, Inc., a wholly owned subsidiary of
Peregrine Pharmaceuticals, Inc. (NASDAQ:
PPHM), announced that the company will exhibit at the
upcoming 2017 BioProcess International Conference & Exhibition,
being held September 25-28, 2017 in Boston, MA. Avid will
showcase the company’s comprehensive range of process development,
analytical development, testing and characterization services
and high-quality cGMP clinical and commercial biologics
manufacturing of monoclonal antibodies and recombinant proteins.
The company’s shares retreated over 40% since July.
22nd Century Group, Inc. (NYSE:
XXII) is a plant biotechnology company focused on the
level of nicotine in tobacco plants and cannabinoids in cannabis
plants. Mitch Zeller, Director, US Food and Drug Administration’s
Center for Tobacco Products. Together with FDA Commissioner, Dr.
Scott Gottlieb, in August 2017, released an article entitled, “A
Nicotine-Focused Framework of Public Health.” The article spells
out the FDA’s regulatory authority for
mandating non-addictive levels of nicotine in combustible
cigarettes. The company’s shares have appreciated over 100% since
June, as the U.S. Government continues its crusade against
nicotine.
Read our recent analyst coverage of these Biotech stocks under the
microscope here READ MORE Copy and paste to
browser may be required- http://tradersnewssource.com/biotechs/
DISCLAIMER
This press release may contain
certain forward-looking statements and information, as defined
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, and is subject
to the Safe Harbor created by those sections. This material
contains statements about expected future events and/or financial
results that are forward-looking in nature and subject to risks and
uncertainties. Such forward-looking statements involve risks,
uncertainties and other factors, which may cause the actual
results, performance or achievements of the subject company in this
report to be materially different from the statements made
herein.
COMPLIANCE PROCEDURE
Content is researched, written and
reviewed on a best-effort basis. Information in this release is
fact checked and produced on a best efforts basis. However, we are
only human and are prone to make mistakes. If you notice any errors
or omissions, please notify us below. The subject Company has not
compensated Traders News Source for the creation or dissemination
of this report. Traders News Source is the party responsible for
issuing the press release and for hosting the full analyst report
on Traders News Source website.
NOT FINANCIAL ADVICE
Traders News Source makes no
warranty, expressed or implied, as to the accuracy or completeness
or fitness for a purpose (investment or otherwise), of the
information provided in this document. This information is not to
be construed as personal financial advice. Readers are encouraged
to consult their personal financial advisor before making any
decisions to buy, sell or hold any securities mentioned
herein.
NO WARRANTY OR LIABILITY
ASSUMED
Traders News Source is not
responsible for any error which may be occasioned at the time of
printing of this document or any error, mistake or shortcoming. No
liability is accepted by Traders News Source whatsoever for any
direct, indirect or consequential loss arising from the use of this
document. Traders News Source expressly disclaims any fiduciary
responsibility or liability for any consequences, financial or
otherwise arising from any reliance placed on the information in
this document. Traders News Source does not (1) guarantee the
accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
Source: Traders News
Source
Contact:
editor@tradersnewssource.com
Ayala Pharmaceuticals (CE) (USOTC:ADXS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ayala Pharmaceuticals (CE) (USOTC:ADXS)
Historical Stock Chart
From Sep 2023 to Sep 2024